Why the study?
Volume overload is associated with mortality in patients with HFrEF, but few studies have examined the relation between volume and long-term kidney function outcomes.
Does volume overload increase the risk of kidney function decline in patients with HFrEF?
Does volume overload increase the risk of kidney function decline in patients with HFrEF?
Volume overload, indicated by elevated natriuretic peptides and congestion scores, is strongly associated with an increased risk of significant kidney function decline in patients with HFrEF.
NT-proBNP elevation may flag higher kidney decline risk in HFrEF; leaves open whether volume control slows progression.
INTRODUCTION: In patients with heart failure with reduced ejection fraction (HFrEF), volume overload is associated with mortality. Few studies that have examined the relation between volume and long-term kidney function outcomes in HFrEF. RESULTS: ), 340 (9%) reached an eGFR decline >40% and 337 (10%) developed incident CKD stage ≥4. In multivariable models, compared with those in the quartile of lowest NT-proBNP, those within the highest quartile had a significantly higher risk of eGFR decline by >40% (hazard ratio [HR] = 2.62 [95% confidence interval {CI} = 1.62, 4.23]) and incident CKD stage ≥4 (HR = 2.66 [95% CI = 1.49, 4.77]), with similar trends for BNP. Similarly in multivariable models, patients in the quartile of highest congestion score had a 48% increased risk for eGFR decline by >40% (HR = 1.48 [95% CI = 1.07, 2.06]) and a 42% increased risk for CKD stage ≥4 (HR = 1.42 [95% CI = 1.01, 1.99]), compared with the lowest quartile. CONCLUSION: Volume overload, as indicated both by elevated natriuretic peptides and clinical signs and symptoms, is associated with increased risk for clinically important kidney function outcomes in HFrEF.
No takes yet. Share an insight, caveat, or question.
McCallum et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: